Á lódáil...
CD73: A potential biomarker for anti-PD-1 therapy
In our recent study, we show that tumoral CD73 expression limits the efficacy of anti-PD-1 therapy, and this is rescued by concomitant A(2A) blockade. Since CD73 is known to be overexpressed in several human cancers and A(2A) antagonists have undergone clinical trials for Parkinson's Disease, t...
Na minha lista:
Foilsithe in: | Oncoimmunology |
---|---|
Main Authors: | , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Taylor & Francis
2015
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4589050/ https://ncbi.nlm.nih.gov/pubmed/26451321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1046675 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|